Lost Money on Corteva, Inc. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 24.30% Share Price Drop
LOS ANGELES--( BUSINESS WIRE)--Investors who lost money on Corteva, Inc. ("Corteva" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of Corteva, Inc. (NYSE: CTVA) investors into whether the Company may have violated the federal securities laws.
Investors who lost money on Corteva, Inc. securities can submit their Corteva, Inc. loss information to learn about potentially pursuing claims to recover their losses.
Key facts in the Corteva, Inc. investigation
What happened?
On November 11, 2026, after the market closed, Corteva reported third quarter 2026 results, and lowered its full-year 2026 outlook due to weaker-than-expected market conditions in Brazil.
On this news, Corteva’s stock price fell $2.95 per share, or 24.30%, to close at $9.19 per share on November 12, 2026, thereby injuring investors.
"Investors who suffered losses deserve to know whether they were given complete and accurate information prior to the disclosure, and our investigation seeks to answer that question," said Charles H. Linehan, Partner at Glancy Prongay Wolke & Rotter LLP.
What's the next step?
Glancy is investigating potential claims on behalf of Corteva, Inc. investors. Investors who lost money can contact Glancy about the Corteva, Inc. investigation, email shareholders@glancylaw.com, or call 310-201-9150 (toll-free: 888-773-9224).
Frequently Asked Questions
Who is eligible? Investors who bought Corteva, Inc. securities and lost money may have claims, and can contact Glancy to learn whether they are affected by the Corteva, Inc. investigation.
What is a securities fraud investigation? In the Corteva, Inc. investigation, Glancy is reviewing whether the Company or its executives may have made false or misleading statements to investors in violation of the federal securities laws.
Has a lawsuit been filed? This release announces Glancy's investigation, not a lawsuit. If a securities class action is later filed against Corteva, Inc., investors may have the opportunity to seek appointment as lead plaintiff.
Does it cost anything to contact Glancy or participate in this investigation? Glancy represents Corteva, Inc. investors on a contingency fee basis, so investors pay no attorneys' fees out of pocket. Any attorneys' fees and litigation expenses are paid only from a recovery, if one is obtained, and are subject to court approval.
Why work with Glancy on the Corteva, Inc. investigation? Glancy Prongay Wolke & Rotter LLP is a premier law firm with decades of experience representing investors and consumers in securities litigation and other complex class action litigation. Contact Glancy about the Corteva, Inc. investigation. Prior results do not guarantee a similar outcome.
Whistleblower notice
Persons with non-public information about Corteva, Inc. should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program. Under the program, whistleblowers who provide original information that leads to a successful SEC enforcement action may receive awards of 10 to 30 percent of the sanctions collected, when those sanctions exceed $1 million. For more information, contact Charles H. Linehan at 310-201-9150 or 888-773-9224, or email shareholders@glancylaw.com.
About Glancy Prongay Wolke & Rotter LLP
Glancy was named one of Law360's Securities Groups of the Year and ranked second in total investor recoveries by ISS Securities Class Action Services in 2025.
Glancy's successes have been widely covered by leading news and industry publications, including The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron's, Investor's Business Daily, Forbes, and Money.
Prior results do not guarantee a similar outcome.
Related links
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.